Evonik Industries (FRA:EVK) has been given a €27.00 ($32.14) target price by UBS in a research report issued on Monday, www.boersen-zeitung.de reports. The brokerage currently has a “sell” rating on the stock. UBS’s price objective suggests a potential downside of 14.53% from the stock’s current price.
EVK has been the topic of several other research reports. Sanford C. Bernstein set a €35.00 ($41.67) price objective on Evonik Industries and gave the stock a “buy” rating in a research note on Monday, March 12th. Baader Bank set a €38.00 ($45.24) target price on Evonik Industries and gave the company a “buy” rating in a research note on Thursday, March 1st. Citigroup set a €36.00 ($42.86) target price on Evonik Industries and gave the company a “buy” rating in a research note on Wednesday, March 21st. Independent Research set a €33.00 ($39.29) target price on Evonik Industries and gave the company a “neutral” rating in a research note on Tuesday, March 6th. Finally, DZ Bank reissued a “buy” rating on shares of Evonik Industries in a research note on Thursday, March 8th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and thirteen have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of €33.70 ($40.11).
FRA EVK opened at €31.59 ($37.61) on Monday. Evonik Industries has a 52 week low of €26.78 ($31.88) and a 52 week high of €32.97 ($39.25).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.